News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Cancer
C. trachomatis may raise risk for precancerous anal lesions in patients with HIV

Study findings showed that patients with HIV who are coinfected with HPV and Chlamydia trachomatis face a substantially increased risk for high-grade anal intraepithelial neoplasia, suggesting that C. trachomatis may enhance the oncogenic potential of HPV, researchers said.

Published
21 July 2019
From
Healio
Cancer
People With HIV Have Good Lung Cancer Surgery Outcomes

HIV-positive people who underwent surgery to remove early lung cancer fared as well as HIV-negative people.

Published
21 July 2019
From
POZ
Hepatitis and HIV
Hepatitis C does not raise risk of heart disease or cancers in people with HIV

Hepatitis C coinfection does not increase the risk of cardiovascular disease or non-AIDS cancers in people with HIV, an analysis of the large Eurosida cohort published in

Published
19 July 2019
By
Keith Alcorn
Vaccinations and immunisations
HPV vaccine for boys 'will prevent thousands of cancers'

Health officials say the HPV vaccine for 12 to 13-year-old boys, starting after the summer, will prevent 29,000 cancers in UK men in the next 40 years.

Published
09 July 2019
From
BBC News
Cancer
Rising Above: People living with HIV are also facing cancer as they age

As a long-term survivor living with HIV, Sean McKenna has faced numerous battles, including two episodes of skin cancer and several bouts of anal precancer. Jill Cadman, another long-timer, is living with HIV and Stage IV colon cancer. And they are not alone.

Published
02 July 2019
From
POZ
Cancer
Breaking down HIV exclusions in cancer clinical trials

As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.

Published
10 June 2019
From
Fred Hutchinson Cancer Research Center
Hepatitis and HIV
Just 18% of people with hepatitis/HIV co-infection and cirrhosis are screened for liver cancer as often as recommended

There is a “strikingly low adherence” to clinical guidelines for ultrasound screening for hepatocellular carcinoma in western Europe, researchers report in the Journal of Viral Hepatitis.Over years

Published
10 June 2019
By
Roger Pebody
Cancer
Checkpoint Immunotherapy Is Safe and Effective for HIV-Positive People With Cancer

Keytruda and Imfinzi were well tolerated and responses were similar to those seen in HIV-negative people.

Published
07 June 2019
From
Poz
Cancer
Advanced Stage at Cancer Diagnosis, Higher Mortality in US Patients With HIV

Cancer patients with HIV in the U.S. are more likely to be diagnosed at advanced disease stages and experience higher cancer-related mortality than cancer patients without HIV, researchers say.

Published
21 May 2019
From
Reuters
Cancer
FDA's Breakthrough Designation Granted for Kaposi Sarcoma Therapy

Celgene’s pomalidomide (Pomalyst) has been granted Breakthrough Therapy designation by the FDA for the treatment of patients with previously-treated HIV-positive Kaposi sarcoma (KS) and patients with HIV-negative KS, according to a press release.

Published
15 May 2019
From
Pharmacy Times
← First12345...55Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.